Quick Answer: GLP-1 receptor agonists may reduce alcohol cravings in some individuals, but they are not FDA-approved for treating alcohol use disorder and evidence remains preliminary
The medication is indicated for adults with type 2 diabetes to improve glycemic control as an adjunct to diet and exercise, and for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
To strike a balance between effectiveness and the risk of reducing stress, physicians should use a cautious, step-by-step approach, giving priority to dietary and lifestyle changes first, then closely monitoring antioxidant supplementation
Dozens of vendors sell lyophilized powder in vials marked "for research purposes only," complete with reconstitution instructions and dosing guides that make the intended use obvious
However, genetic predisposition is not destinylifestyle, nutrition, and biomarker status also matter significantly